Cytotoxic treatment of adrenocortical carcinoma, World Journal of Surgery, vol.52, issue.7, pp.927-933, 2001. ,
DOI : 10.1002/1097-0142(19930515)71:10<2900::AID-CNCR2820711003>3.0.CO;2-S
An original procedure for preparation of nanocapsules of polyalkylcyanoacrylates for interfacial polymerization, Pharma Acta Helv, vol.61, pp.10-11, 1986. ,
Drug-loaded nanoparticles: Preparation methods and drug targeting tissues, Review Eur J Biopharm, vol.39, issue.5, pp.173-191, 1993. ,
Management of adrenocortical carcinoma, Clinical Endocrinology, vol.111, issue.3, pp.273-287, 2004. ,
DOI : 10.1002/cncr.11084
A theoretical basis for a biopharmaceutic drug classification : The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharmaceutical Research, vol.12, issue.3, pp.413-420, 1995. ,
DOI : 10.1023/A:1016212804288
Estimating human oral fraction dose absorbed : A correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds, Pharmaceutical Research, vol.05, issue.10, pp.651-654, 1988. ,
DOI : 10.1023/A:1015927004752
Effect on Cerebral Blood Flow of Orally Administered Indomethacin-loaded Poly(isobutylcyanoacrylate) and Poly(DL-lactide) Nanocapsules, Journal of Pharmacy and Pharmacology, vol.2, issue.8, pp.42-558, 1990. ,
DOI : 10.1002/art.1780310314
Determination of Mitotane (o,p`-DDD) and its Metabolites o,p`-DDA and o,p`-DDE in Plasma by High-Performance Liquid Chromatography, Therapeutic Drug Monitoring, vol.21, issue.3, pp.355-359, 1999. ,
DOI : 10.1097/00007691-199906000-00020
Mitotane-induced febrile pancytopenia: a first case report in paraneoplastic Cushing's syndrome, European Journal of Endocrinology, vol.144, issue.1, p.81, 2001. ,
DOI : 10.1530/eje.0.1440081
Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine, Biology of the Cell, vol.61, issue.1-2, pp.69-76, 1987. ,
DOI : 10.1111/j.1768-322X.1987.tb00571.x
The Novel Formulation Design of Self-emulsifying Drug Delivery Systems (SEDDS) Type O/W Microemulsion III: The Permeation Mechanism of a Poorly Water Soluble Drug Entrapped O/W Microemulsion in Rat Isolated Intestinal Membrane by the Ussing Chamber Method, Drug Metabolism and Pharmacokinetics, vol.21, issue.1, pp.45-53, 2006. ,
DOI : 10.2133/dmpk.21.45
Caco-2 monolayers in experimental and theoretical predictions of drug transport, Adv Drug Deliv Rev, vol.46, pp.1-3, 2001. ,
Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS), European Journal of Pharmaceutical Sciences, vol.35, issue.4, pp.257-263, 2008. ,
DOI : 10.1016/j.ejps.2008.07.004
Formulation of Insulin-Loaded Polymeric Nanoparticles Using Response Surface Methodology, Drug Development and Industrial Pharmacy, vol.31, issue.2, pp.179-189, 2005. ,
DOI : 10.3109/10837459609031423
Surfactant systems: Their chemistry, pharmacy and biology, 1983. ,
DOI : 10.1007/978-94-009-5775-6
[practical use of o,p'ddd in adrenocortical carcinoma], Bull Cancer, vol.92, issue.3, pp.273-279, 2005. ,
Enhanced oral bioavailability of dexibuprofen by a novel solid sedds formulation Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'ddd) levels on the treatment of patients with adrenocortical carcinoma, Eur J Pharm Biopharm Cancer, vol.92, issue.6, pp.1385-1392, 2001. ,
Rapid micromethod for the analysis of mitotane and its metabolite in plasma by gas chromatography with electron-capture detection, Journal of Chromatography B: Biomedical Sciences and Applications, vol.417, issue.2, pp.287-294, 1987. ,
DOI : 10.1016/0378-4347(87)80122-6
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery, Journal of Controlled Release, vol.62, issue.1-2, pp.25-31, 1999. ,
DOI : 10.1016/S0168-3659(99)00034-6
Chemotherapy of adrenocortical cancer with o,p'-ddd (rothane) Annals of Internal Medicine, pp.672-682, 1960. ,
Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma, British Journal of Cancer, vol.78, issue.4, pp.546-549, 1998. ,
DOI : 10.1038/bjc.1998.530
Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.69, issue.2, pp.436-444, 2008. ,
DOI : 10.1016/j.ejpb.2007.12.012
Novel poloxamer-based nanoemulsions to enhance the intestinal absorption of active compounds, International Journal of Pharmaceutics, vol.329, issue.1-2, pp.173-181, 2007. ,
DOI : 10.1016/j.ijpharm.2006.08.022
Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing, Cancer Res, vol.47, issue.4, pp.936-942, 1987. ,
Action of 1,1,Dichloro-2-p-chlorophenyl-2-o-chlorophenylethane on Dog Adrenal Cortex, Science, vol.136, issue.3510, p.47, 1962. ,
DOI : 10.1126/science.136.3510.47
Dissolution Characteristics of Polycaprolactone-Polylactide Microspheres of Chlorpromazine, Drug Development and Industrial Pharmacy, vol.13, issue.14, pp.2355-2380, 1986. ,
DOI : 10.1007/978-1-4684-7239-4_2
A guide to Ussing chamber studies of mouse intestine, American Journal of Physiology-Gastrointestinal and Liver Physiology, vol.296, issue.6, pp.1151-1166, 2009. ,
DOI : 10.1113/jphysiol.2003.060046
Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration, Advanced Drug Delivery Reviews, vol.60, issue.6, pp.747-756, 2008. ,
DOI : 10.1016/j.addr.2007.09.009
Lipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspects, Pharmaceutical Research, vol.12, issue.11, pp.1561-1572, 1995. ,
DOI : 10.1023/A:1016268311867
An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy, International Journal of Pharmaceutics, vol.114, issue.1, pp.103-110, 1995. ,
DOI : 10.1016/0378-5173(94)00222-Q
Human Pharmacology of Griseofulvin: The Effect of Fat Intake on Gastrointestinal Absorption11From the Department of Dermatology, University of Miami Medical School, Miami, Florida., Journal of Investigative Dermatology, vol.37, issue.6, pp.529-533, 1961. ,
DOI : 10.1038/jid.1961.154
Emulsification through Area Contraction, Journal of Colloid and Interface Science, vol.210, issue.1, pp.222-224, 1999. ,
DOI : 10.1006/jcis.1998.5943
Adrenal cortical carcinoma, World Journal of Surgery, vol.12, issue.7, pp.914-926, 2001. ,
DOI : 10.1200/JCO.1994.12.6.1272
Atovaquone and rifabutine-loaded nanocapsules: formulation studies, International Journal of Pharmaceutics, vol.153, issue.1, pp.127-130, 1997. ,
DOI : 10.1016/S0378-5173(97)00076-8
Intestinal absorption of plaga microspheres in the rat, J Anat, vol.189, issue.3, pp.491-501, 1996. ,
Normal and Promoted Gastrointestinal Absorption of Water-Soluble Substances I: Induced Rapidly Reversible Hyperabsorptive State in the Canine Fundic Stomach Pouch, Journal of Pharmaceutical Sciences, vol.59, issue.7, pp.960-963, 1970. ,
DOI : 10.1002/jps.2600590708
A new simple hplc method for measuring mitotane and its two principal metabolites tests in animals and mitotane-treated patients, J Chromatogr B Analyt Technol Biomed Life Sci, vol.837, pp.1-2, 2006. ,
Is there a role for low doses of mitotane (o,p'-ddd) as adjuvant therapy in adrenocortical carcinoma, J Clin Endocrinol Metab, vol.83, issue.9, pp.3100-3103, 1998. ,
Acrylic polymers. A review of pharmaceutical applications, S.T.P. Pharma Sci, vol.7, pp.403-437, 1997. ,
Vaccinecontaining biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response, Adv Exp Med Biol, vol.251, pp.191-202, 1989. ,
Microparticle targeting to M cells, Advanced Drug Delivery Reviews, vol.34, issue.2-3, pp.261-283, 1998. ,
DOI : 10.1016/S0169-409X(98)00043-X
Procédé de préparation de systèmes colloïdaux dispersibles d'une substance sous forme de nanoparticules. Brevet français, pp.608-988, 1988. ,
Tissue Distribution and Elimination of DDD and DDT Following Oral Administration to Dogs and Rats., Experimental Biology and Medicine, vol.72, issue.2, pp.357-360, 1949. ,
DOI : 10.3181/00379727-72-17431
Surfactant/cosurfactant association and emulsion stability, J Am Oil Chem Soc, vol.59, issue.12, pp.569-572, 1982. ,
Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs, European Journal of Pharmaceutics and Biopharmaceutics, vol.50, issue.1, pp.179-188, 2000. ,
DOI : 10.1016/S0939-6411(00)00089-8
Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge, Pharmaceutical Research, vol.15, issue.6, pp.863-869, 1998. ,
DOI : 10.1023/A:1011968313933
Poly(??-caprolactone) and Eudragit?? microparticles containing fludrocortisone acetate, International Journal of Pharmaceutics, vol.269, issue.2, pp.491-508, 2004. ,
DOI : 10.1016/j.ijpharm.2003.09.040
URL : https://hal.archives-ouvertes.fr/hal-00399629
Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: Investigating the relationship between physicochemical characteristics and dissolution behaviour, European Journal of Pharmaceutical Sciences, vol.35, issue.1-2, pp.104-113, 2008. ,
DOI : 10.1016/j.ejps.2008.06.010
Alginate/poly-l-lysine microparticles for the intestinal delivery of antisense oligonucleotides, Pharmaceutical Research, vol.19, issue.6, pp.755-764, 2002. ,
DOI : 10.1023/A:1016188312399
Bioavailability of seocalcitol, European Journal of Pharmaceutical Sciences, vol.28, issue.3, pp.233-242, 2006. ,
DOI : 10.1016/j.ejps.2006.02.005
Bioavailability of seocalcitol, European Journal of Pharmaceutical Sciences, vol.31, issue.1, pp.8-15, 2007. ,
DOI : 10.1016/j.ejps.2007.01.007
Circulation lymphatique. In : Physiologie Humaine. Paris : Pradel, pp.136-138, 1991. ,
Effect of Food on the Pharmacokinetics of Cyclosporine in Healthy Subjects Following Oral and Intravenous Administration, The Journal of Clinical Pharmacology, vol.17, issue.Suppl 5, pp.643-653, 1990. ,
DOI : 10.1023/A:1015939307478
Poly (DL-lactide) nanocapsules containing diclofenac: I. Formulation and stability study, International Journal of Pharmaceutics, vol.113, issue.1, pp.57-63, 1995. ,
DOI : 10.1016/0378-5173(94)00177-7
Prolonged bleeding time due to mitotane therapy, European Journal of Cancer and Clinical Oncology, vol.27, issue.5, pp.638-641, 1991. ,
DOI : 10.1016/0277-5379(91)90233-4
Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients, British Journal of Cancer, vol.69, issue.5, pp.947-951, 1994. ,
DOI : 10.1038/bjc.1994.183
Pharmacokinetics of the adrenocorticolytic compounds 3-methylsulphonyl-DDE and o,p???-DDD (mitotane) in Minipigs, Cancer Chemotherapy and Pharmacology, vol.72, issue.352, pp.267-274, 2008. ,
DOI : 10.1016/j.scitotenv.2004.10.031
Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa, Pharmaceutical Research, vol.07, issue.9, pp.902-910, 1990. ,
DOI : 10.1023/A:1015937605100
Risk factors for adrenal cancer: An exploratory study, International Journal of Cancer, vol.39, issue.4, pp.432-436, 1996. ,
DOI : 10.1002/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y
The preparation and acute antihypertensive effects of a nanocapsular form of darodipine, a dihydropyridine calcium entry blocker, Pharmaceutical Research, vol.08, issue.6, pp.734-738, 1991. ,
DOI : 10.1023/A:1015897900363
Lipid-based vehicles for the oral delivery of poorly water soluble drugs, Advanced Drug Delivery Reviews, vol.25, issue.1, pp.103-128, 1997. ,
DOI : 10.1016/S0169-409X(96)00494-2
Adrenal cortical carcinoma, The American Journal of Medicine, vol.41, issue.4, pp.581-592, 1966. ,
DOI : 10.1016/0002-9343(66)90220-8
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency, Journal of Pharmacy and Pharmacology, vol.35, issue.12, pp.821-826, 1990. ,
DOI : 10.1146/annurev.me.35.020184.000523
Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose, International Journal of Pharmaceutics, vol.86, issue.2-3, pp.2-3, 1992. ,
DOI : 10.1016/0378-5173(92)90202-D
Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells, Cell & Tissue Research, vol.162, issue.Suppl 2, pp.399-405, 1993. ,
DOI : 10.1093/infdis/162.4.896
Improved bioavailability of vitamin E with a self emulsifying formulation, International Journal of Pharmaceutics, vol.200, issue.1, pp.53-57, 2000. ,
DOI : 10.1016/S0378-5173(00)00337-9
Fluorescence Study of the Membrane-Perturbing Action of Sodium Caprylate as Related to Promotion of Drug Absorption, Journal of Pharmaceutical Sciences, vol.77, issue.5, pp.390-392, 1988. ,
DOI : 10.1002/jps.2600770506
Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs, International Journal of Pharmaceutics, vol.274, issue.1-2, pp.1-2, 2004. ,
DOI : 10.1016/j.ijpharm.2003.12.028
Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs, Journal of Controlled Release, vol.102, issue.2, pp.489-507, 2005. ,
DOI : 10.1016/j.jconrel.2004.10.030
Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine, International Journal of Pharmaceutics, vol.167, issue.1-2, pp.155-164, 1998. ,
DOI : 10.1016/S0378-5173(98)00054-4
A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa, Pharm Res, vol.10, issue.12, pp.1710-1714, 1993. ,
Enhanced absorption of indomethacin after oral or rectal administration of a self-emulsifying system containing indomethacin to rats, International Journal of Pharmaceutics, vol.194, issue.1, pp.81-89, 2000. ,
DOI : 10.1016/S0378-5173(99)00367-1
Reductive Metabolism of p,p'-DDT and o,p'-DDT by Rat Liver Cytochrome P450, Drug Metabolism and Disposition, vol.30, issue.2, p.113, 2002. ,
DOI : 10.1124/dmd.30.2.113
Application of Measurements of Transepithelial Electrical Resistance of Intestinal Epithelial Cell Monolayers To Evaluate Probiotic Activity, Applied and Environmental Microbiology, vol.71, issue.11, pp.71-7528, 2005. ,
DOI : 10.1128/AEM.71.11.7528-7530.2005
Viability and permeability across Caco-2 cells of CBZ solubilized in fully dilutable microemulsions, Colloids and Surfaces B: Biointerfaces, vol.66, issue.1, pp.1-12, 2008. ,
DOI : 10.1016/j.colsurfb.2008.05.006
Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment, International Journal of Pharmaceutics, vol.212, issue.2, 2001. ,
DOI : 10.1016/S0378-5173(00)00614-1
Separation and Characterization of the Colloidal Phases Produced on Digestion of Common Formulation Lipids and Assessment of Their Impact on the Apparent Solubility of Selected Poorly Water-Soluble Drugs, Journal of Pharmaceutical Sciences, vol.92, issue.3, pp.634-648, 2003. ,
DOI : 10.1002/jps.10329
Comparison between active and passive drug transport in human intestinal epithelial (caco-2) cells in vitro and human jejunum in vivo, International Journal of Pharmaceutics, vol.127, issue.1, pp.103-107, 1996. ,
DOI : 10.1016/0378-5173(95)04204-0
New approach for the preparation of nanoparticles by an emulsification-diffusion method, Eur J Pharm Biopharm, vol.41, issue.1, pp.14-18, 1995. ,
Preparation of Poly(methylmethacrylate) Microcapsules with Liquid Cores, Journal of Colloid and Interface Science, vol.208, issue.1, pp.49-62, 1998. ,
DOI : 10.1006/jcis.1998.5698
The intestinal epithelial barrier: How to distinguish between the microbial flora and pathogens, Seminars in Immunology, vol.19, issue.2, pp.106-115, 2007. ,
DOI : 10.1016/j.smim.2006.12.006
Formation of simvastatin nanoparticles from microemulsion, Nanomedicine: Nanotechnology, Biology and Medicine, vol.5, issue.3, 2008. ,
DOI : 10.1016/j.nano.2008.11.004
Binding and uptake of biodegradable poly-dl-lactide micro- and nanoparticles in intestinal epithelia, European Journal of Pharmaceutical Sciences, vol.6, issue.2, pp.153-163, 1998. ,
DOI : 10.1016/S0928-0987(97)10007-0
Improved nasal absorption of drugs using poly-l-arginine: effects of concentration and molecular weight of poly-l-arginine on the nasal absorption of fluorescein isothiocyanate???dextran in rats, European Journal of Pharmaceutics and Biopharmaceutics, vol.52, issue.1, pp.21-30, 2001. ,
DOI : 10.1016/S0939-6411(01)00149-7
Mechanism of nanocapsules formation by the emulsion???diffusion process, Journal of Colloid and Interface Science, vol.317, issue.2, pp.458-468, 2008. ,
DOI : 10.1016/j.jcis.2007.09.081
Blood levels of o,p???-DDD following administration in various vehicles after a single dose and during long-term treatment, Cancer Chemotherapy and Pharmacology, vol.7, issue.1, pp.51-54, 1981. ,
DOI : 10.1007/BF00258213
Studies of the pharmacology of o,p'ddd in man, J Lab Clin Med, vol.58, pp.296-304, 1961. ,
LONG-TERM FOLLOW-UP OF ADRENOCORTICAL CARCINOMA PATIENTS TREATED WITH ADJUVANT LOW-DOSE MITOTANE (O, P', -DDD), European Urology Supplements, vol.5, issue.2, pp.150-150, 2006. ,
DOI : 10.1016/S1569-9056(06)60515-0
Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(p-chlorophenyl)-1,1-dichloroethane (ddd or tde) Virchows Archiv fuer Pathologische Anatomie und Physiologie und fuer Klinische Medizin, pp.387-394, 1949. ,
[hepatotoxicity of a synthetic cortisol antagonist: Op'ddd (mitotane)], Therapie, vol.56, issue.6, pp.793-797, 2001. ,
(parachlorophenyl)-1, 1- dichloroethane, Studies on ddd, pp.2-310, 1957. ,
Oral microemulsions of paclitaxel: In situ and pharmacokinetic studies, European Journal of Pharmaceutics and Biopharmaceutics, vol.71, issue.2, pp.310-317, 2009. ,
DOI : 10.1016/j.ejpb.2008.08.015
The effect of physical barriers and properties on the oral absorption of particulates, Advanced Drug Delivery Reviews, vol.34, issue.2-3, pp.135-154, 1998. ,
DOI : 10.1016/S0169-409X(98)00037-4
Preparation of microspheres by the solvent evaporation technique, Advanced Drug Delivery Reviews, vol.28, issue.1, pp.25-42, 1997. ,
DOI : 10.1016/S0169-409X(97)00049-5
Lipid-based formulations for intestinal lymphatic delivery, European Journal of Pharmaceutical Sciences, vol.15, issue.5, pp.405-415, 2002. ,
DOI : 10.1016/S0928-0987(02)00051-9
Link between drug absorption solubility and permeability measurements in Caco-2 cells, Journal of Pharmaceutical Sciences, vol.87, issue.12, pp.1604-1607, 1998. ,
DOI : 10.1021/js980111k
Uptake and translocation of fluorescent latex particles by rabbit peyer's patch follicle epithelium: A quantitative model for m cell uptake, Clin Exp Immunol, vol.76, issue.1, pp.144-148, 1989. ,
Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay, Cancer Res, issue.22, pp.47-5875, 1987. ,
Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules, Pharmaceutical Research, vol.47, issue.6, pp.1243-1250, 2006. ,
DOI : 10.1111/j.1768-322X.1987.tb00571.x
Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues, Journal of Controlled Release, vol.2, pp.257-275, 1985. ,
DOI : 10.1016/0168-3659(85)90050-1
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: Studies with halofantrine, Journal of Pharmaceutical Sciences, vol.93, issue.5, pp.1110-1121, 2004. ,
DOI : 10.1002/jps.20039
Lymphatic Transport of Halofantrine in the Triple-Cannulated Anesthetized Rat Model: Effect of Lipid Vehicle Dispersion, Journal of Pharmaceutical Sciences, vol.85, issue.4, pp.351-356, 1996. ,
DOI : 10.1021/js950221g
Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification, International Journal of Pharmaceutics, vol.27, issue.2-3, pp.335-348, 1985. ,
DOI : 10.1016/0378-5173(85)90081-X
Formulation of self-emulsifying drug delivery systems, Advanced Drug Delivery Reviews, vol.25, issue.1, pp.47-58, 1997. ,
DOI : 10.1016/S0169-409X(96)00490-5
Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system, European Journal of Pharmaceutical Sciences, vol.29, issue.3-4, pp.3-4, 2006. ,
DOI : 10.1016/j.ejps.2006.04.016
Formulation of lipid-based delivery systems for oral administration: Materials, methods and strategies, Advanced Drug Delivery Reviews, vol.60, issue.6, pp.625-637, 2008. ,
DOI : 10.1016/j.addr.2007.10.010
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery, Pharmaceutical Research, vol.25, issue.3, pp.549-556, 2006. ,
DOI : 10.1111/j.2042-7158.1990.tb07033.x
Transmucosal macromolecular drug delivery, Journal of Controlled Release, vol.101, issue.1-3, pp.151-162, 2005. ,
DOI : 10.1016/j.jconrel.2004.07.030
Vectorisation et vecteurs de médicaments, S.T.P. Pharma. Sciences, vol.5, pp.107-113, 1989. ,
Effectiveness and Toxicity Screening of Various Absorption Enhancers Using Caco-2 Cell Monolayers., Biological & Pharmaceutical Bulletin, vol.21, issue.6, pp.615-620, 1998. ,
DOI : 10.1248/bpb.21.615
Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique, International Journal of Pharmaceutics, vol.143, issue.2, pp.133-141, 1996. ,
DOI : 10.1016/S0378-5173(96)04697-2
Aromatic hydroxylation and alkyl oxidation in metabolism of mitotane (o,p'-ddd) in humans, J Pharm Sci, vol.63, issue.11, pp.1730-1736, 1974. ,
Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice, International Journal of Pharmaceutics, vol.126, issue.1-2, pp.253-260, 1995. ,
DOI : 10.1016/0378-5173(95)04135-4
Phase studies and particle size analysis of oil-in-water phospholipid microemulsions, International Journal of Pharmaceutics, vol.116, issue.2, pp.253-261, 1995. ,
DOI : 10.1016/0378-5173(94)00316-W
A study of particulate intestinal absorption and hepatocellular uptake, Experimental Cell Research, vol.22, pp.137-145, 1961. ,
DOI : 10.1016/0014-4827(61)90092-1
Permeability of PBCA Nanoparticles through Porcine Small Intestine, Journal of Drug Targeting, vol.7, issue.1, pp.21-27, 1993. ,
DOI : 10.1146/annurev.me.35.020184.000523
Effect of Vehicle Amphiphilicity on the Dissolution and Bioavailability of a Poorly Water-Soluble Drug from Solid Dispersions, Journal of Pharmaceutical Sciences, vol.77, issue.5, pp.414-417, 1988. ,
DOI : 10.1002/jps.2600770512
Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells, European Journal of Pharmaceutical Sciences, vol.24, issue.5, pp.477-486, 2005. ,
DOI : 10.1016/j.ejps.2005.01.001
Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells, European Journal of Pharmaceutical Sciences, vol.24, issue.5, pp.477-486, 2005. ,
DOI : 10.1016/j.ejps.2005.01.001
Development and bioavailability assessment of ramipril nanoemulsion formulation, European Journal of Pharmaceutics and Biopharmaceutics, vol.66, issue.2, pp.227-243, 2007. ,
DOI : 10.1016/j.ejpb.2006.10.014
Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs, International Journal of Pharmaceutics, vol.106, issue.1, pp.15-23, 1994. ,
DOI : 10.1016/0378-5173(94)90271-2
Mechanism of intestinal fatty acid uptake in the rat: the role of an acidic microclimate., The Journal of Physiology, vol.421, issue.1, pp.463-474, 1990. ,
DOI : 10.1113/jphysiol.1990.sp017955
Modulation of Intestinal P-Glycoprotein Function by Cremophor EL and Other Surfactants by an In Vitro Diffusion Chamber Method Using the Isolated Rat Intestinal Membranes, Journal of Pharmaceutical Sciences, vol.93, issue.4, pp.877-885, 2004. ,
DOI : 10.1002/jps.20017
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery, Biomaterials, vol.30, issue.12, pp.30-2329, 2009. ,
DOI : 10.1016/j.biomaterials.2008.12.066
Solubilizing Excipients in Oral and Injectable Formulations, Pharmaceutical Research, vol.21, issue.2, pp.201-230, 2004. ,
DOI : 10.1023/B:PHAM.0000016235.32639.23
Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size, Pharmaceutical Research, vol.06, issue.1, pp.40-43, 1989. ,
DOI : 10.1023/A:1015843517762
Adjuvant Mitotane Treatment for Adrenocortical Carcinoma, New England Journal of Medicine, vol.356, issue.23, pp.356-2372, 2007. ,
DOI : 10.1056/NEJMoa063360
Low-Dose Monitored Mitotane Treatment Achieves the Therapeutic Range with Manageable Side Effects in Patients with Adrenocortical Cancer, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.6, pp.2234-2238, 2000. ,
DOI : 10.1210/jc.85.6.2234
[metabolism of o,p'-ddd (mitotane) in human and animals. Actual notions and practical deductions (author's transl)], Ann Endocrinol, vol.38, issue.1, pp.13-25, 1977. ,
Cushing's syndrome. Therapy directed at the adrenal glands, 1994. ,
Emulsions containing partially water-miscible solvents for the preparation of drug nanosuspensions, Journal of Controlled Release, vol.76, issue.1-2, pp.119-128, 2001. ,
DOI : 10.1016/S0168-3659(01)00432-1
Adrenal atrophy effects in animals In : Proceedings of the chemotherapy conference on ortho para' ddd. Edited by le broder, sk carter, bethesda, Cancer therapy Evaluation Branch, N. C. I, pp.6-16, 1970. ,
Cyclodextrin Drug Carrier Systems, Chemical Reviews, vol.98, issue.5, pp.98-2045, 1998. ,
DOI : 10.1021/cr970025p
??-Caprolactone and its Polymers, Journal of the American Chemical Society, vol.56, issue.2, pp.455-459, 1934. ,
DOI : 10.1021/ja01317a053
The treatment of adrenocortical carcinoma with o,p???-DDD: Prognostic simplications of serum level monitoring, European Journal of Cancer and Clinical Oncology, vol.20, issue.1, 1984. ,
DOI : 10.1016/0277-5379(84)90033-6
Rationale for the development of sandimmune neoral, Transplant Proc, vol.26, issue.5, pp.2925-2927, 1994. ,
Cushing's Syndrome Due to Adrenocortical Hyperplasia, New England Journal of Medicine, vol.265, issue.22, pp.1088-1093, 1961. ,
DOI : 10.1056/NEJM196111302652204
Systemic availability of o,p'-ddd in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism, Res Vet Sci, vol.43, issue.2, pp.160-165, 1987. ,
Dechlorination of 1,1,1-trichloro-2, 2-bis (p-chlorophelyl) ethane by aerobacter aerogenes i. Metabolic products, Appl. Microbiol, vol.15, issue.3, pp.569-574, 1967. ,
Differentiated intestinal epithelial cell lines asin vitro models for predicting the intestinal absorption of drugs, Cell Biology and Toxicology, vol.269, issue.5-6, pp.5-6, 1994. ,
DOI : 10.1007/BF00755788
A novel phdependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs, J Control Release, vol.98, issue.2, pp.219-229, 2004. ,
Biopharmaceutics Classification of Selected ??-Blockers:?? Solubility and Permeability Class Membership, Molecular Pharmaceutics, vol.4, issue.4, pp.608-614, 2007. ,
DOI : 10.1021/mp070028i
In vitro permeability across caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth, Pharmaceutical Research, vol.14, issue.6, pp.763-766, 1997. ,
DOI : 10.1023/A:1012102522787
Molecular weight dependence of permselectivity to rat small intestinal blood-lymph barrier for exogenous macromolecules absorbed from lumen., Journal of Pharmacobio-Dynamics, vol.7, issue.1, pp.1-6, 1984. ,
DOI : 10.1248/bpb1978.7.1
Preparation and evaluation of self-microemulsifying drug delivery system of oridonin, International Journal of Pharmaceutics, vol.355, issue.1-2, pp.269-276, 2008. ,
DOI : 10.1016/j.ijpharm.2007.12.026